Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)

Randall J. Brenneman; Edward Soffen; Hiram A. Gay; Peter F. Orio; John P. Christodouleas; John C. Baumann; Brian C. Baumann

doi:10.21037/tau.2019.03.14

Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)

Randall J. Brenneman, Edward Soffen, Hiram A. Gay, Peter F. Orio, John P. Christodouleas, John C. Baumann, Brian C. Baumann

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	S265-S270
Journal	Translational Andrology and Urology
Volume	8
DOIs	https://doi.org/10.21037/tau.2019.03.14
State	Published - 2019

Access to Document

10.21037/tau.2019.03.14

Cite this

Brenneman, R. J., Soffen, E., Gay, H. A., Orio, P. F., Christodouleas, J. P., Baumann, J. C., & Baumann, B. C. (2019). Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526). Translational Andrology and Urology, 8, S265-S270. https://doi.org/10.21037/tau.2019.03.14

@article{36d9e4724b644239a90419699622dade,

title = "Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)",

author = "Brenneman, {Randall J.} and Edward Soffen and Gay, {Hiram A.} and Orio, {Peter F.} and Christodouleas, {John P.} and Baumann, {John C.} and Baumann, {Brian C.}",

year = "2019",

doi = "10.21037/tau.2019.03.14",

language = "English",

volume = "8",

pages = "S265--S270",

journal = "Translational Andrology and Urology",

issn = "2223-4683",

}

Brenneman, RJ, Soffen, E, Gay, HA, Orio, PF, Christodouleas, JP, Baumann, JC & Baumann, BC 2019, 'Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)', Translational Andrology and Urology, vol. 8, pp. S265-S270. https://doi.org/10.21037/tau.2019.03.14

Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526). / Brenneman, Randall J.; Soffen, Edward; Gay, Hiram A. et al.
In: Translational Andrology and Urology, Vol. 8, 2019, p. S265-S270.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)

AU - Brenneman, Randall J.

AU - Soffen, Edward

AU - Gay, Hiram A.

AU - Orio, Peter F.

AU - Christodouleas, John P.

AU - Baumann, John C.

AU - Baumann, Brian C.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85072110323&partnerID=8YFLogxK

U2 - 10.21037/tau.2019.03.14

DO - 10.21037/tau.2019.03.14

M3 - Review article

C2 - 31392141

AN - SCOPUS:85072110323

SN - 2223-4683

VL - 8

SP - S265-S270

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

ER -

Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)

Access to Document

Other files and links

Cite this